Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT05890001 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.

NCT NCT05890001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
Lead sponsor
Braintree Laboratories
Phase
Phase 3
Overall status
Completed
Start date
April 5, 2023
Completion date
October 8, 2024
Enrollment
400 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

erosive esophagitis, non-erosive reflux disease